Paradigm Biocapital Advisors’s Seagen Inc. Common Stock SGEN Stock Holding History

Paradigm Biocapital Advisors’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-281,969	Closed	-$57.1M	–	35
2023 Q1	$57.1M	Sell	281,969 -4,319	-2%	-$693K	5.41%	5
2022 Q4	$36.8M	Buy	+286,288	New	+$36.9M	4.32%	12
2022 Q1	–	Sell	-100,687	Closed	-$15.6M	–	30
2021 Q4	$15.6M	Buy	+100,687	New	+$16.9M	4.45%	10

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Paradigm Biocapital Advisors's SGEN Position: Q2 2023 in Review

Paradigm Biocapital Advisors sold out of Seagen Inc. Common Stock (SGEN) in Q2 2023, closing a stake of 281,969 shares — an estimated $57.1M sold.

Paradigm Biocapital Advisors first reported a position in SGEN in Q4 2021 and held it in 3 quarters. The position peaked at $57.1M in Q1 2023. 594 funds tracked by Wall St. Rank hold SGEN as of Q2 2023.

Paradigm Biocapital Advisors reported no remaining Seagen Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Paradigm Biocapital Advisors sold 281,969 Seagen Inc. Common Stock shares in Q2 2023, an estimated $57.1M.
Paradigm Biocapital Advisors first reported a position in Seagen Inc. Common Stock in Q4 2021 and held it in 3 quarters.
Paradigm Biocapital Advisors's Seagen Inc. Common Stock position peaked at $57.1M in Q1 2023.
594 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2023.

Based on Paradigm Biocapital Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.